The company collaborates with academic research groups to develop novel nano-scale fibres and coatings for scientific research. They manufacture nanofibrous biomaterials that mimic the human body's natural extracellular matrix, which can be used in post-surgery recovery, implantable tissue-regenerative devices, 3D cell structure, and drug discovery. The company's biomaterial is the first electrospun material to be incorporated into an FDA-approved medical device that promotes endogenous tissue repair in orthopaedic surgery. They support customers from developing electrospun prototypes towards registration with the FDA or notified bodies and long term manufacturing. The company has over 30 years of combined experience in biomedical electrospinning and operates out of Class VII clean rooms with ISO 13485:2016 medical device quality certification.